Atrial Fibrillation and Flutter in a Contemporary Cohort of Patients With Myotonic Muscular Dystrophy
JACC: Clinical Electrophysiology · 2025
DOI: 10.1016/j.jacep.2024.12.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2025. Verfasst von Melissa A Austin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: melissa.austin@pennmedicine.…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Atrial Flutter, Myotonic Dystrophy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Literature on the prevalence and management of atrial arrhythmias in patients with myotonic muscular dystrophy type 1 (MMD1) or myotonic muscular dystrophy type 2 (MMD2) is limited. OBJECTIVES: This study sought to describe incidence, prevalence, and predictors of atrial fibrillation (AF) and atrial flutter (AFL) in a contemporary cohort of patients with myotonic muscular dystrophy (MMD). METHODS: Associations between patient factors and incident AF/AFL were analyzed in patients with MMD referred for routine electrophysiology evaluation between January 2013 and September 2023. RESULTS: We identified 120 patients (96 MMD1, 24 MMD2) seen for new electrophysiology clinic visits for MMD cardiac evaluation. Median age at MMD diagnosis was 34.6 years (Q1-Q3: 21.8-51.0 years), with a younger age at diagnosis for MMD1 patients (P < 0.001). AF or AFL was diagnosed in 31% of patients (31 of 96 MMD1 patients vs 6 of 24 MMD2 patients; P = 0.656) during the study period. AF occurred in 34 (28%) patients, AFL in 9 (8%), and 6 of 37 had both AF and AFL. Anticoagulation (AC) was prescribed at initial AF/AFL diagnosis in 41% (n = 15 of 37) of patients. The CHA2DS2-VASc score was higher in patients who received AC (P < 0.001). Twelve (32%) patients underwent catheter ablation. One stroke occurred in the AF/AFL group (no AC, CHA2DS2-VASc score 0). Female MMD1 patients were less likely to develop AF/AFL (HR: 0.08). Diagnosis of MMD1 at a younger age (HR: 0.95 per year) and greater CTG nucleotide repeats (HR: 1.09 per 50 repeats) were associated with incident AF/AFL. CONCLUSIONS: There was a high prevalence of AF/AFL in this single-institution MMD cohort. The CHA2DS2-VASc score may not be an effective tool in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: melissa.austin@pennmedicine.upenn.edu.
- Section of Cardiac Electrophysiology, Cardiovascular Medicine Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Zitieren
APA
Austin, M. A., Supple, G. E., Carrell, S., Quinn, C., Elman, L., & Nazarian, S. (2025). Atrial Fibrillation and Flutter in a Contemporary Cohort of Patients With Myotonic Muscular Dystrophy. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2024.12.007
Vancouver
Austin MA, Supple GE, Carrell S, Quinn C, Elman L, Nazarian S. Atrial Fibrillation and Flutter in a Contemporary Cohort of Patients With Myotonic Muscular Dystrophy. JACC: Clinical Electrophysiology. 2025. doi:10.1016/j.jacep.2024.12.007
BibTeX
@article{Austin2025,
author = {Austin, Melissa A and Supple, Gregory E and Carrell, Samuel and Quinn, Colin and Elman, Lauren and Nazarian, Saman},
title = {Atrial Fibrillation and Flutter in a Contemporary Cohort of Patients With Myotonic Muscular Dystrophy},
journal = {JACC: Clinical Electrophysiology},
year = {2025},
doi = {10.1016/j.jacep.2024.12.007}
}
EUVIMED